George Kaiser Family Foundation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Sell
434
-52
-11% -$53.1K 0.05% 52
2026
Q1
$447K Hold
486
– – 0.05% 40
2025
Q4
$522K Hold
486
– – 0.07% 29
2025
Q3
$371K Hold
486
– – 0.05% 61
2025
Q2
$379K Buy
486
+177
+57% +$138K 0.05% 63
2025
Q1
$255K Buy
+309
New +$257K 0.04% 64

Other funds holding LLY

George Kaiser Family Foundation's LLY Position: Q2 2026 in Review

George Kaiser Family Foundation reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $53.1K and leaving 434 shares worth $521K. The position accounts for 0.05% of the portfolio, ranked #52.

George Kaiser Family Foundation first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $522K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • George Kaiser Family Foundation held 434 shares of Eli Lilly worth $521K as of Q2 2026.
  • George Kaiser Family Foundation sold 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
  • Eli Lilly made up 0.05% of George Kaiser Family Foundation's portfolio in Q2 2026, its #52 holding.
  • George Kaiser Family Foundation first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • George Kaiser Family Foundation's Eli Lilly position peaked at $522K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on George Kaiser Family Foundation's 13F filing for Q2 2026, filed 12 Aug 2026.